DOSE-RESPONSE STUDY OF METFORMIN AND CARDIOVASCULAR RISK-FACTORS IN TYPE-2 DIABETES

被引：0
|
作者：
GRANT, PJ [1 ]
机构：
[1] GEN INFIRM,DIV MED,DIABET & THROMBOSIS RES GRP,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND
来源：
DIABETOLOGIA | 1994年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A200 / A200
页数：1
相关论文
共 50 条
  • [41] Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies
    Yao, Baodong
    Fang, Hong
    Xu, Wanghong
    Yan, Yujie
    Xu, Huilin
    Liu, Yinan
    Mo, Miao
    Zhang, Hua
    Zhao, Yanping
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2014, 29 (02) : 79 - 88
  • [42] THE RELATIONSHIP OF CARDIOVASCULAR RISK-FACTORS TO THE PREVALENCE OF CORONARY HEART-DISEASE IN NEWLY DIAGNOSED TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES
    UUSITUPA, M
    SIITONEN, O
    PYORALA, K
    ARO, A
    HERSIO, K
    PENTTILA, I
    VOUTILAINEN, E
    DIABETOLOGIA, 1985, 28 (09) : 653 - 659
  • [43] Parity and risk of type 2 diabetes: a systematic review and dose-response meta-analysis
    Li, Peiyun
    Shan, Zhilei
    Zhou, Li
    Xie, Manling
    Bao, Wei
    Zhang, Yan
    Rong, Ying
    Yang, Wei
    Liu, Liegang
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 175 (05) : R231 - R245
  • [44] Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes
    Chen, C. -H.
    Lin, C. -L.
    Hsu, C. -Y.
    Kao, C. -H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (03) : 194 - 200
  • [45] The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes
    Grant, PJ
    DIABETES CARE, 1996, 19 (01) : 64 - 66
  • [46] Dose-response association of metformin use and risk of age-related macular degeneration among patients with type 2 diabetes mellitus: a population-based study
    Huang, Kuang-Hua
    Chang, Ya-Lan
    Lee, Chiachi Bonnie
    Gau, Shuo-Yan
    Tsai, Tung-Han
    Chung, Ning-Jen
    Lee, Chien-Ying
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [47] Efficacy of metformin in type II diabetes: A placebo-controlled, multi-center, dose-response study.
    Garber, AJ
    Mills, DJ
    Young, DA
    Rohlf, JL
    Cryer, DR
    DIABETES, 1997, 46 : 398 - 398
  • [48] Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus
    Abbasi, F
    Chu, JW
    McLaughlin, T
    Lamendola, C
    Leary, ET
    Reaven, GM
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (02): : 159 - 164
  • [49] HYPERTENSION IN DIABETES STUDY (HDS) .1. PREVALENCE OF HYPERTENSION IN NEWLY PRESENTING TYPE-2 DIABETIC-PATIENTS AND THE ASSOCIATION WITH RISK-FACTORS FOR CARDIOVASCULAR AND DIABETIC COMPLICATIONS
    TURNER, RC
    HOLMAN, RR
    MATTHEWS, DR
    BASSETT, PA
    COSTER, R
    STRATTON, IM
    CULL, CA
    PETO, R
    FRIGHI, V
    KENNEDY, IA
    MANLEY, SE
    BOWN, EG
    EELEY, EA
    ROSS, I
    MATTHEWS, DR
    DORNAN, TL
    WRIGHT, AD
    NEIL, HAW
    KOHNER, EM
    ALDINGTON, S
    KEEN, N
    ROSE, C
    FLETCHER, AE
    BATTERSBY, C
    YUDKIN, JS
    OAKES, SF
    TURNER, RC
    HOLMAN, RR
    STEARN, MR
    PALMER, SL
    HAMMERSLEY, MS
    FRANKLIN, SL
    SPIVEY, RS
    HOCKADAY, TDR
    MURCHISON, LE
    BRUNT, AHE
    WILLIAMS, MJ
    MACPEARSON, DW
    PETRIE, XMP
    LEAN, MEJ
    WRIGHT, AD
    LEVI, NA
    SHEARER, ACI
    THOMPSON, RJW
    KOHNER, EM
    DODDRIDGE, MC
    HAYES, JR
    HENRY, RW
    FETHERSTON, MS
    HADDEN, DR
    JOURNAL OF HYPERTENSION, 1993, 11 (03) : 309 - 317
  • [50] STUDY OF PREVALENCE OF CARDIOVASCULAR RISK-FACTORS
    DELULUAGA, IY
    DEMAZZUCCO, OS
    KIRZNER, T
    BARMAT, R
    LAJFER, J
    PLOTQUIN, Y
    PRENSA MEDICA ARGENTINA, 1984, 71 (01): : 15 - 23
12345